Journal of Contemporary Brachytherapy

Full text

3/2026 vol. 18
Original paper

Applicator-dependent differences between TG-43 and a grid-based Boltzmann solver in iridium-192 high-dose-rate gynecological brachytherapy

Bojan Pavičar 1, 2
,
Andrej Milosavljević 2
,
Branko Predojević 3
,
Borislava Petrović 1, 4

  1. Faculty of Sciences, Department of Physics, University of Novi Sad, 21000 Novi Sad, Serbia

  2. Radiotherapy Department, International Medical Centers, 78000 Banja Luka, Bosnia and Herzegovina

  3. Faculty of Natural Sciences and Mathematics, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina

  4. Radiotherapy Clinic, Oncology Institute of Vojvodina, 21204 Sremska Kamenica, Serbia

J Contemp Brachytherapy 2026; 18, 3: 279–287

DOI: https://doi.org/10.5114/jcb.2026.164555
Data publikacji online: 2026/09/30
Article files
Applicator-dependent differences - supplementary materials.pdf Applicator-dependent differences.pdf
  1. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting brachytherapy for cancer of the cervix. ICRU Report 89. J ICRU 2016; 16: 1-138.
  2. Pötter R, Tanderup K, Schmid MP et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60.
  3. Nath R, Anderson LL, Luxton G et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 1995; 22: 209-234.
  4. Rivard MJ, Coursey BM, DeWerd LA et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004; 31: 633-674.
  5. Rivard MJ, Butler WM, DeWerd LA et al. Supplement to the 2004 update of the AAPM Task Group No. 43 Report. Med Phys 2007; 34: 2187-2205.
  6. Beaulieu L, Carlsson Tedgren Å, Carrier JF et al. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys 2012; 39: 6208-6236.
  7. Beaulieu L, Ballester F, Granero D et al. AAPM WGDCAB Report 372: a joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy. Med Phys 2023; 50: e946-e960.
  8. Sinnatamby M, Nagarajan V, Reddy KS et al. Comparison of image-based three-dimensional treatment planning using AcurosTM BV and AAPM TG-43 algorithm for intracavitary brachytherapy of carcinoma cervix. J Radiother Pract 2016; 15: 254-262.
  9. Hofbauer J, Kirisits C, Resch A et al. Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy. J Contemp Brachytherapy 2016; 8: 143-149.
  10. Hyer DE, Sheybani A, Jacobson GM et al. The dosimetric impact of heterogeneity corrections in high-dose-rate 192Ir brachytherapy for cervical cancer: investigation of both conventional Point-A and volume-optimized plans. Brachytherapy 2012; 11: 515-520.
  11. Bi SY, Chen ZJ, Sun XR et al. Dosimetric comparison of AcurosBV with AAPM TG43 dose calculation formalism in cervical intraductal high-dose-rate brachytherapy using three different applicators. Precis Radiat Oncol 2022; 6: 234-242.
  12. Mikell JK, Klopp AH, Gonzalez GMN et al. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 2012; 83: e417-e422.
  13. Jacob D, Lamberto M, Lawrence LD et al. Clinical transition to model-based dose calculation algorithm: a retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix. Brachytherapy 2017; 16: 624-629.
  14. Abe K, Kadoya N, Miyasaka Y et al. Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer. J Radiat Res 2018; 59: 198-206.
  15. Radcliffe BA, Kim Y, Raffi J et al. Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism. J Appl Clin Med Phys 2025; 26: e14549.
  16. Srivastava S, Venugopal AK, Singh MN. Effect of model-based dose-calculation algorithms in high dose rate brachytherapy of cervical carcinoma. Rep Pract Oncol Radiother 2024; 29: 300-308.
  17. Meftahi M, Song WY. The effect of vaginal cylinder inhomogeneity on the HDR brachytherapy dose calculations using Monte Carlo simulations. J Appl Clin Med Phys 2024; 25: e14228.
  18. Kishigami Y, Ono T, Matsushita N et al. Influence of applicator models on dose distribution in gynecologic high-dose-rate brachytherapy. Radiol Phys Technol 2026; 19: 157-164.
  19. Tran D, Duong TT, Wadi-Ramahi S et al. Beyond TG-43: a PRISMA-based systematic review on model-based dose-calculation algorithms in brachytherapy. J Appl Clin Med Phys 2026; 27: e70627.
  20. Varian Medical Systems. BrachyVision Instructions for Use. Version 15.5. Varian Medical Systems; Palo Alto 2017.
  21. Varian Medical Systems. BrachyVision Algorithms Reference Guide. Version 15.5. Varian Medical Systems; Palo Alto 2017.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications